Wavefront-guided versus cross-cylinder photorefractive keratectomy in moderate-to-high astigmatism: a cohort of two consecutive clinical trials.

Although there have been many studies of the efficacy and safety of wavefront- guided (WF) and cross-cylinder photorefractive keratectomy (PRK), there are few studies on moderate-to-high astigmatism cases. The aim of this study was to assess and compare the efficacy of WF and cross-cylinder PRK in moderate-to-high astigmatism.
In a comparative cohort, the results of two before-and-after clinical trials conducted on moderate-to-high astigmatism were studied. In the first trial, 50 eyes of 25 patients with stable refraction were enrolled in a before-and-after clinical trial to undergo WF PRK using the VISX™ (VISX Inc, Santa Clara, CA) system. The second clinical trial enrolled 48 eyes of 24 patients with stable refraction and moderate-to-high astigmatism to undergo PRK by the cross-cylinder method using a NIDEK EC-5000 excimer laser system (NIDEK Co Ltd, Gamagori, Japan).
After 6 months, 80% of the eyes in the WF group had uncorrected visual acuity of 20/20 or better compared to 40% in the cross-cylinder group. Only one eye in the cross-cylinder group and no eyes in the WF group lost more than one line of best corrected visual acuity (BCVA) after 6 months of treatment. No treated eyes in either group lost more than two lines of BCVA. The percentage of eyes with no change in BCVA was 54% and 58.3% in the WF and cross-cylinder groups, respectively. Mean postoperative absolute changes in total root-mean-square higher order aberrations in the WF group and cross-cylinder group were 0.05 ± 0.22 μm and 0.17 ± 0.20 μm, respectively (P < 0.001).
Both methods of PRK, using the NIDEK EC-5000 and VISX excimer laser systems, are effective for correcting moderate-to-high astigmatism. The WF approach appeared more successful in improving the refractive results.
AuthorsM R Sedghipour, R Sorkhabi, A Mostafaei
JournalClinical ophthalmology (Auckland, N.Z.) (Clin Ophthalmol) Vol. 6 Pg. 199-204 ( 2012) ISSN: 1177-5483 [Electronic] New Zealand
PMID22331978 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: